Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia. Jebanesan DZP, Illangeswaran RSS, Rajamani BM, Vidhyadharan RT, et al. Ann Hematol 2024 Apr 17. doi: 10.1007/s00277-024-05742.

Read + Share

Amedeo Smart

Independent Medical Education

Jebanesan DZP, Illangeswaran RSS, Rajamani BM, Vidhyadharan RT, et al. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia. Ann Hematol 2024 Apr 17. doi: 10.1007/s00277-024-05742.
PMID: 38630133